JP2017532378A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017532378A5 JP2017532378A5 JP2017538918A JP2017538918A JP2017532378A5 JP 2017532378 A5 JP2017532378 A5 JP 2017532378A5 JP 2017538918 A JP2017538918 A JP 2017538918A JP 2017538918 A JP2017538918 A JP 2017538918A JP 2017532378 A5 JP2017532378 A5 JP 2017532378A5
- Authority
- JP
- Japan
- Prior art keywords
- phospholipid
- polymer
- liposome composition
- aromatic
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462061514P | 2014-10-08 | 2014-10-08 | |
| US62/061,514 | 2014-10-08 | ||
| US201562111057P | 2015-02-02 | 2015-02-02 | |
| US62/111,057 | 2015-02-02 | ||
| PCT/US2015/054732 WO2016057812A1 (en) | 2014-10-08 | 2015-10-08 | Mri imaging of amyloid plaque using liposomes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017532378A JP2017532378A (ja) | 2017-11-02 |
| JP2017532378A5 true JP2017532378A5 (enExample) | 2018-11-22 |
| JP6505235B2 JP6505235B2 (ja) | 2019-04-24 |
Family
ID=55653789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017538918A Active JP6505235B2 (ja) | 2014-10-08 | 2015-10-08 | リポソームを用いるアミロイド斑のｍｒｉイメージング |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US9744251B2 (enExample) |
| EP (3) | EP3542828A1 (enExample) |
| JP (1) | JP6505235B2 (enExample) |
| KR (1) | KR102409017B1 (enExample) |
| CN (1) | CN107106708B (enExample) |
| AU (2) | AU2015330824A1 (enExample) |
| CA (1) | CA2963941C (enExample) |
| ES (2) | ES3032054T3 (enExample) |
| MX (1) | MX371295B (enExample) |
| WO (1) | WO2016057812A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9801957B2 (en) | 2011-04-06 | 2017-10-31 | Ananth Annapragada | Lipid-based nanoparticles |
| EP2756459B1 (en) | 2012-01-20 | 2020-12-09 | Ananth Annapragada | Methods and compositions for objectively characterizing medical images |
| EP3542828A1 (en) | 2014-10-08 | 2019-09-25 | Texas Children's Hospital | Mri imaging of amyloid plaque using liposomes |
| EP3487545A1 (en) | 2016-07-22 | 2019-05-29 | AC Immune S.A. | Compounds for imaging tau protein aggregates |
| WO2018015549A1 (en) | 2016-07-22 | 2018-01-25 | Ac Immune S.A. | Compounds for imaging tau protein aggregates |
| US11052162B2 (en) | 2016-09-16 | 2021-07-06 | Texas Children's Hospital | Liposomal gadolinium (GD) contrast agent “NMRX” for T1-MRI |
| EP3548002B1 (en) | 2016-11-30 | 2025-04-30 | Texas Children's Hospital | Hydrophilic fluorinated molecules for liposomal 19f mri probes with unique mr signatures |
| EP3743426A1 (en) | 2018-01-24 | 2020-12-02 | AC Immune SA | Azacarboline compounds for the detection of tau aggregates |
| WO2019145291A1 (en) | 2018-01-24 | 2019-08-01 | Ac Immune Sa | Gamma-carboline compounds for the detection of tau aggregates |
| CN116173238A (zh) * | 2018-03-29 | 2023-05-30 | 微脉管治疗有限公司 | 用于检测和治疗阿尔茨海默病的组合物及方法 |
| WO2019234243A1 (en) | 2018-06-08 | 2019-12-12 | Ac Immune Sa | Novel compounds for diagnosis |
| JP7545393B2 (ja) * | 2019-01-24 | 2024-09-04 | アルゼカ バイオサイエンシズ、エルエルシー | 誤って折りたたまれたタンパク質を画像化するための機能化リポソーム |
| CN114341364B (zh) * | 2019-07-08 | 2025-07-18 | 阿尔兹卡生物科学公司 | Tau病理靶向配体 |
| US11614451B2 (en) | 2019-07-08 | 2023-03-28 | Alzeca Biosciences, LLC | Targeting ligands for tau pathology |
| KR102546470B1 (ko) * | 2020-01-29 | 2023-06-21 | 텍사스 칠드런스 하스피탈 | 아밀로이드 침착의 mri용 표적 조영제 |
| WO2021163585A1 (en) | 2020-02-12 | 2021-08-19 | Texas Children's Hospital | Targeted contrast agents for mri of alpha-synuclein deposition |
| US11779664B2 (en) | 2020-02-12 | 2023-10-10 | Texas Children's Hospital | Targeted contrast agents for MRI of alpha-synuclein deposition |
| CN115970009A (zh) * | 2023-02-08 | 2023-04-18 | 丽水市中心医院 | Vhpk多肽修饰的荧光纳米脂质体给药系统、其制备方法及应用 |
| CN116869938A (zh) * | 2023-07-26 | 2023-10-13 | 安徽医科大学 | 一种1,2,4-噁二唑-吡啶脂质体及其制备方法和应用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204085A (en) | 1985-01-08 | 1993-04-20 | Mallinckrodt Medical, Inc. | Method for enhancing the safety of metal-ligand chelates as X-ray contrast agents |
| CN1148812A (zh) | 1994-03-28 | 1997-04-30 | 尼科梅德成像有限公司 | “脂质体” |
| US6071532A (en) | 1996-10-15 | 2000-06-06 | Emory University | Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
| JP4829454B2 (ja) | 1999-11-30 | 2011-12-07 | ジ・アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティ・オブ・アリゾナ | 放射線感受性リポソーム |
| WO2002028441A2 (en) | 2000-10-04 | 2002-04-11 | California Institute Of Technology | Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits |
| WO2002094191A2 (en) | 2001-05-23 | 2002-11-28 | New York University | Detection of alzheimer's amyloid by magnetic resonance imaging |
| AU2003217950A1 (en) | 2002-03-05 | 2003-09-22 | Cleveland State University | Agglomerated particles for aerosol drug delivery |
| EP1641742A4 (en) | 2003-05-01 | 2006-11-29 | Nst Neurosurvival Technologies | COMPOUNDS BINDING SELECTIVELY TO MEMBRANES OF APOPTOTIC CELLS |
| US7208174B2 (en) | 2003-12-18 | 2007-04-24 | Hoffmann-La Roche Inc. | Liposome compositions |
| US20100031378A1 (en) | 2008-08-04 | 2010-02-04 | Edwards Joel A | Novel gene disruptions, compositions and methods relating thereto |
| US8357351B2 (en) | 2004-04-21 | 2013-01-22 | Ananth Annapragada | Nano-scale contrast agents and methods of use |
| US7713517B2 (en) | 2004-04-21 | 2010-05-11 | Marval Biosciences, Inc. | Compositions and methods for enhancing contrast in imaging |
| WO2006032705A2 (en) | 2004-09-23 | 2006-03-30 | Guerbet | Contrast agents encapsulating systems for cest imaging |
| WO2007041855A1 (en) | 2005-10-13 | 2007-04-19 | Waratah Pharmaceuticals, Inc. | Scyllo-inositol derivatives and their use in the treatment of diseases characterised by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence |
| WO2007048019A2 (en) | 2005-10-20 | 2007-04-26 | The Penn State Research Foundation | Delivery system for diagnostic and therapeutic agents |
| US20090123047A1 (en) | 2007-03-21 | 2009-05-14 | Yfantis Spyros A | Method and system for characterizing prostate images |
| EP1982733A1 (en) | 2007-04-17 | 2008-10-22 | Bayer Schering Pharma Aktiengesellschaft | Use of a contrast agent for magnetic resonance imaging of endoleaks |
| WO2008134618A2 (en) | 2007-04-27 | 2008-11-06 | The General Hospital Corporation | Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders |
| CA2695204A1 (en) | 2007-07-26 | 2009-01-29 | Nanoscan Imaging, Llc | Methods for imaging using improved nanoparticulate contrast agents |
| CA2708028A1 (en) | 2007-12-05 | 2009-06-11 | Marval Biosciences, Inc. | Nano-scale contrast agents and methods of use |
| CN102037004A (zh) * | 2008-01-08 | 2011-04-27 | 生物种属学股份公司 | 使用寡糖基转移酶的多肽的糖缀合 |
| ITMI20081052A1 (it) | 2008-06-10 | 2009-12-11 | Univ Milano Bicocca | Liposomi in grado di legare efficacemente il peptide beta-amiloide |
| WO2009152445A1 (en) | 2008-06-13 | 2009-12-17 | Marval Biosciences, Inc. | Imaging of atherosclerotic plaques using liposomal imaging agents |
| WO2010017094A2 (en) | 2008-07-31 | 2010-02-11 | The General Hospital Corporation | CURCUMIN DERIVATIVES FOR AMYLOID-β PLAQUE IMAGING |
| AR074760A1 (es) * | 2008-12-18 | 2011-02-09 | Metabolex Inc | Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico. |
| JP2012520898A (ja) | 2009-03-19 | 2012-09-10 | マーヴァル バイオサイエンシーズ，インコーポレイテッド | 画像化におけるコントラスト強調のための組成物および方法 |
| US20120263646A1 (en) | 2009-10-15 | 2012-10-18 | Guerbet | Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases |
| ES2526124T3 (es) * | 2010-06-16 | 2015-01-07 | Cymabay Therapeutics, Inc. | Agonistas del receptor GPR120 y sus usos |
| AU2012223210B2 (en) | 2011-03-02 | 2016-12-22 | Board Of Regents Of The University Of Texas System | Vesicle compositions |
| US9801957B2 (en) * | 2011-04-06 | 2017-10-31 | Ananth Annapragada | Lipid-based nanoparticles |
| GB201112056D0 (en) | 2011-07-14 | 2011-08-31 | Univ Leuven Kath | Antibodies |
| EP2756459B1 (en) | 2012-01-20 | 2020-12-09 | Ananth Annapragada | Methods and compositions for objectively characterizing medical images |
| WO2013164763A2 (en) | 2012-04-30 | 2013-11-07 | Innovative Health Diagnostics | A biological complex specific for alzheimer's disease detection in vitro and use thereof |
| AU2014240042C1 (en) * | 2013-03-14 | 2019-09-05 | Celltaxis, Llc | Inhibitors of leukotriene A4 hydrolase |
| EP3542828A1 (en) | 2014-10-08 | 2019-09-25 | Texas Children's Hospital | Mri imaging of amyloid plaque using liposomes |
-
2015
- 2015-10-08 EP EP19172751.0A patent/EP3542828A1/en not_active Withdrawn
- 2015-10-08 CA CA2963941A patent/CA2963941C/en active Active
- 2015-10-08 ES ES22152987T patent/ES3032054T3/es active Active
- 2015-10-08 AU AU2015330824A patent/AU2015330824A1/en not_active Abandoned
- 2015-10-08 ES ES15849750T patent/ES2743704T3/es active Active
- 2015-10-08 KR KR1020177012354A patent/KR102409017B1/ko active Active
- 2015-10-08 WO PCT/US2015/054732 patent/WO2016057812A1/en not_active Ceased
- 2015-10-08 US US14/878,745 patent/US9744251B2/en active Active
- 2015-10-08 JP JP2017538918A patent/JP6505235B2/ja active Active
- 2015-10-08 EP EP15849750.3A patent/EP3204051B1/en active Active
- 2015-10-08 CN CN201580066712.6A patent/CN107106708B/zh active Active
- 2015-10-08 EP EP22152987.8A patent/EP4035688B1/en active Active
- 2015-10-08 MX MX2017004695A patent/MX371295B/es active IP Right Grant
-
2016
- 2016-12-01 US US15/366,667 patent/US10537649B2/en active Active
-
2019
- 2019-11-08 US US16/677,751 patent/US20200069820A1/en not_active Abandoned
-
2020
- 2020-02-14 US US16/791,068 patent/US11141495B2/en active Active
-
2021
- 2021-05-25 AU AU2021203388A patent/AU2021203388B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Manganese-based contrast agents for magnetic resonance imaging of liver tumors: structure-activity relationships and lead candidate evaluation | |
| TW319763B (enExample) | ||
| US11141495B2 (en) | MRI imaging of amyloid plaque using liposomes | |
| US8647604B2 (en) | Lanthanide rich nanoparticles, and their investigative uses in MRI and related technologies | |
| JP6212032B2 (ja) | 脂質ベースのナノ粒子 | |
| CN108289970A (zh) | 包含mri造影剂的组合的制剂 | |
| JP2014523854A5 (enExample) | ||
| JP7114074B2 (ja) | 画像化のためのニトロキシドを含むアミロイド結合剤およびその治療的使用 | |
| Urbanovsky et al. | Lanthanide complexes of DO3A–(Dibenzylamino) methylphosphinate: effect of Protonation of the Dibenzylamino Group on the water-exchange rate and the binding of human serum albumin | |
| WO2010141704A2 (en) | Imaging of myelin basic protein | |
| CN1487947A (zh) | 顺磁性金属-酞菁配位化合物和使用其的造影剂 | |
| Lucas et al. | Comparison of a tartaric acid derived polymeric MRI contrast agent to a small molecule model chelate | |
| KR102931218B1 (ko) | 자기 공명 영상(MRI)에 의한 β-아밀로이드 플라크의 검출용 조영제로서 나프탈렌 유도체와 접합된 금속 산화물 나노입자 | |
| JP4786112B2 (ja) | 金属イオンキレート化錯体と共役させた胆汁酸誘導体の微小血管の診断評価のための使用 | |
| Pushparaj et al. | Trinuclear Gd (III) metal complex with amide core display remarkable enhancement in relaxivity | |
| JP2022523056A5 (enExample) | ||
| Granato et al. | Synthesis and relaxometric characterization of new Poly [N, N‐bis (3‐aminopropyl) glycine](PAPGly) Dendrons Gd‐based contrast agents and their in vivo study by using the dynamic contrast‐enhanced MRI technique at low field (1 T) | |
| WO2007128567A1 (de) | Verwendung von perfluoralkylhaltigen metallkomplexen als kontrastmittel zur diagnose der alzheimer krankheit | |
| Chang et al. | Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine | |
| Petiet et al. | Improvement of microscopic MR imaging of amyloid plaques with targeting and non-targeting contrast agents | |
| US20230022136A1 (en) | Diffusivity contrast agents for medical imaging | |
| Djanashvili et al. | Responsive nanozeolites: Smart porosity and surface tailoring for multimodal imaging and therapy of cancer | |
| Burke et al. | Contrast enhancement of liver lesions in cirrhotic patients: a single institution crossover comparative study of two MR contrast agents. Preliminary results | |
| KR101480393B1 (ko) | 간암 진단을 위한 조영제용 가돌리늄 착물과 이를 이용한 간암 진단용 조영제 | |
| Fransen et al. | r1 and r2 Relaxivities of Dendrons Based on a OEG‐DTPA Architecture: Effect of Gd3+ Placement and Dendron Functionalization |